Cereno`s HDAC inhibitor reduces risks from PAH in phase 2 trial
30 Sep 2024 //
FIERCE BIOTECH
Cereno Scientific obtains first patent in Europe for drug candidate CS585
23 Sep 2022 //
CISION
Cereno broadens patent protection for drug candidate CS585
09 Sep 2022 //
CISION